NCT05215873View on ClinicalTrials.gov

Induction of Labor in Pregnant Women With Prelabor Rupture of Membranes - Oxytocin or Misoprostol

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

January 15, 2022

Study Completion Date

May 16, 2022

Conditions
Prelabor Rupture of Membranes
Interventions
DRUG

Misoprostol

a synthetic prostaglandin E1 analogue

DRUG

Syntocinon

synthetic oxytocin

Trial Locations (1)

Unknown

Ain Shams Maternity Hospital, Cairo

All Listed Sponsors
lead

Ain Shams Maternity Hospital

OTHER

NCT05215873 - Induction of Labor in Pregnant Women With Prelabor Rupture of Membranes - Oxytocin or Misoprostol | Biotech Hunter | Biotech Hunter